University of Rochester Medical Center
Rochester, New York, 14642, United States
Location status: Recruiting
Location contact
Francisco Cartujano, MD
CONTACT
Francisco Cartujano, MD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07227480
The purpose of this study is to assess the feasibility, acceptability, and preliminary impact of text messaging to promote lung cancer screening.
Interested in participating?
Request Info50 year–80 year
All sexes
Interventional
Not applicable
Rochester, New York, 14642, United States
Location status: Recruiting
Francisco Cartujano, MD
CONTACT
Francisco Cartujano, MD
PRINCIPAL_INVESTIGATOR
We will conduct a two-arm pilot randomized controlled trial with 40 adults. Participants will be randomized in a 1:1 ratio to either UR Screened (a text messaging program designed to promote lung cancer screening) or a control group (a mailed educational material along with a flyer for the lung cancer screening program). We will assess recruitment and follow-up rates, satisfaction with the program or educational material, and uptake of lung cancer screening at week 12. Additionally, we will compare screening rates between the intervention and control groups.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A text messaging program designed to promote lung cancer screening
A mailed educational material along with a flyer for the lung cancer screening program
Time frame: Month 3
The proportion of study participants who complete a lung cancer screening test within 3 months of study enrollment
Contact information is provided by the study sponsor or research team.
University of Rochester
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07682610
Lung Cancer Screening
Ashland, Kentucky, United States
View Trial DetailsNCT07682597
Lung Cancer Screening
Greenville, Mississippi, United States
View Trial DetailsNCT07639255
Lung Cancer Screening
Ashland, Kentucky, United States
View Trial DetailsNCT06538636
Lung Cancer, Lung Cancer Screening
Bedford, Massachusetts, United States
View Trial Details